These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17505023)

  • 1. Induction of a distinct CD8 Tnc17 subset by transforming growth factor-beta and interleukin-6.
    Liu SJ; Tsai JP; Shen CR; Sher YP; Hsieh CL; Yeh YC; Chou AH; Chang SR; Hsiao KN; Yu FW; Chen HW
    J Leukoc Biol; 2007 Aug; 82(2):354-60. PubMed ID: 17505023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
    Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
    J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets.
    Erard F; Garcia-Sanz JA; Moriggl R; Wild MT
    J Immunol; 1999 Jan; 162(1):209-14. PubMed ID: 9886388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
    Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
    Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The differentiation and regulation of antigen-specific Th17 cells].
    Yang J; Jia L; Li L; Wu CY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):213-6. PubMed ID: 18328176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.
    Tajima M; Wakita D; Satoh T; Kitamura H; Nishimura T
    Int Immunol; 2011 Dec; 23(12):751-9. PubMed ID: 22039016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
    Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
    J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of CD8+ T cells by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1993 Jul; 151(2):668-77. PubMed ID: 8335902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltration of tumor-reactive transforming growth factor-beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cells.
    Zhang Q; Jang TL; Yang X; Park I; Meyer RE; Kundu S; Pins M; Javonovic B; Kuzel T; Kim SJ; Van Parijs L; Smith N; Wong L; Greenberg NM; Guo Y; Lee C
    Prostate; 2006 Feb; 66(3):235-47. PubMed ID: 16173028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis.
    Egan PJ; van Nieuwenhuijze A; Campbell IK; Wicks IP
    Arthritis Rheum; 2008 Dec; 58(12):3720-9. PubMed ID: 19035489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-kappa B ligand, interleukin (IL) -17, IL-10 and transforming growth factor-beta during the progression of chronic periodontitis.
    Dutzan N; Gamonal J; Silva A; Sanz M; Vernal R
    J Clin Periodontol; 2009 May; 36(5):396-403. PubMed ID: 19419438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta is necessary for induction of IL-23R and Th17 differentiation by IL-6 and IL-23.
    Morishima N; Mizoguchi I; Takeda K; Mizuguchi J; Yoshimoto T
    Biochem Biophys Res Commun; 2009 Aug; 386(1):105-10. PubMed ID: 19501566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine NKT cells produce Th17 cytokine interleukin-22.
    Goto M; Murakawa M; Kadoshima-Yamaoka K; Tanaka Y; Nagahira K; Fukuda Y; Nishimura T
    Cell Immunol; 2009; 254(2):81-4. PubMed ID: 19010461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack.
    Koehler H; Kofler D; Hombach A; Abken H
    Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
    Kim S; Shen T; Min B
    J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.